day 301 – why joining tissue studies is vital to ushering in the era of personalized cancer therapy
Earlier this week I blogged about the cancer conference, the WIN Symposium which I attended last week. I summarized some of the current challenges in developing personalized cancer therapies, including the complexity of cancer. The […]